P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS. (23rd June 2022) - Zinzani, P. L.; Zain, J.; Mead, M.; Casulo, C.; Jacobsen, E. D.; Gritti, G.; Pinter-Brown, L.; Isutzu, K.; Cohan, D.; Daugherty, M.; Brammer, J. E.; Mehta-Shah, N.; et al.